USPTO serial 87784846
ONESOURCE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 5, 2022
- Examiner
- WATSON, BRIDGET ANNE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ONESOURCE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Shelton, CT
PerkinElmer Health Sciences, Inc.
Waltham, MA
PerkinElmer Health Sciences, Inc.
Waltham, MA
PerkinElmer Health Sciences, Inc.
Waltham, MA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina M. Licursi
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Relocation services for businesses, namely, laboratories; relocation services for scientific, pharmaceutical, and medical research, analytical, and diagnostic laboratories, namely, inventory recordation and equipment labeling in the nature of inventory management and transportation logistics, namely, arranging the transportation of goods for others; services in the nature of arranging transportation of specimens, chemicals, and samples for others; business management consulting services, namely, laboratory application efficiency and method consulting and design for scientific research and medical analytical and diagnostic laboratories in the nature of identification of customer objectives and goals and providing strategic recommendations; business management consulting services, namely, research, analysis, and reporting in the field of workflow, productivity analysis, and personnel management in scientific, pharmaceutical, and medical research, analytical, and diagnostic laboratories for business purposes; consulting services, namely, providing business information and business management advice to others for maintaining, optimizing, and extending the lifecycle and productivity of analytical and diagnostic laboratory equipment; business management consulting services in the field of purchases, namely, assisting laboratories with the purchase of scientific, pharmaceutical, and medical research, analytical, and diagnostic instruments; business management consulting services in the field of science and technology, namely, assisting laboratories with identifying scientific, pharmaceutical, and medical research, analytical, and diagnostic instruments for purchase; employment staffing services, namely, filling the temporary staffing needs of scientific, pharmaceutical, and medical research, analytical, and diagnostic laboratories; benchmarking services for scientific, medical, and pharmaceutical research and diagnostic laboratories and equipment, namely, analyzing and providing business strategic planning feedback regarding performance efficiency, usage and throughput, regulatory compliance, and quality standards; information technology support services in the nature of asset management and risk mitigation, namely, reporting on service histories, utilization of the medical assets, end of product life information and replacement costs all related to medical diagnostic, clinical and biomedical equipment | ACTIVE | Mar 10, 2003 |
| 037 | Installation, maintenance, optimization in the nature of repair consultation, repair, and refurbishment of laboratory instruments for scientific, pharmaceutical, and medical research, analysis, and diagnostic use; Installation, maintenance, optimization in the nature of repair consultation, repair, and refurbishment of computer hardware for scientific, medical, and pharmaceutical research, analysis, and diagnostics use; Laboratory equipment installation for scientific, pharmaceutical, and medical research, analytical, and diagnostic laboratories | ACTIVE | Mar 10, 2003 |
| 041 | Training services, namely, business training advisory and consultancy services relating to the use, handling, optimization, calibration, and maintenance of laboratory equipment and related software; educational services, namely, conducting technical discussion meetings and technical training seminars on topics of business, administration operation, regulatory and standards compliance, and management of scientific, pharmaceutical, and medical research, analytical and diagnostic laboratories, experimental testing and analysis, data management, and quality assurance | ACTIVE | Mar 10, 2003 |
| 042 | Data services, namely, data integrity governance, data management, data reporting, data monitoring, data translation, data transformation, data storage, data analytics, and data integration for data generated in scientific, pharmaceutical, and medical research, analytical and diagnostic laboratories; computer support services for laboratories, namely, providing information technology technical support performed by science-knowledgeable professionals, and electronic monitoring of data from laboratory instruments for quality control purposes; information technology services in the nature of planning, designing, implementing, deploying, installing, customizing, integrating, managing, migrating, testing, validating, and supporting of scientific and laboratory informatics data systems, applications, processes, and technologies; analytics services in the nature of implementation and management of web portals, mobile applications, interactive dashboards, connected instrument utilization, RFID powered asset location, predictive maintenance, and data-driven prescriptive recommendations in the fields of scientific, pharmaceutical, and medical research and diagnostic laboratories; remote technical and diagnostic support in the nature of monitoring technological functions of laboratory instruments for scientific, medical, and pharmaceutical research and diagnostics use; remote technical and diagnostic support in the nature of monitoring technological functions of computer hardware for scientific, research, medical, and diagnostics use; technology testing, inspection, evaluation, verification, analysis and development of laboratory equipment and protocols to verify compliance with regulatory, quality, quantity, consistency, performance, ethical or safety standards; computational chemistry services in the nature of biological research for identification, design, optimization, and study of biologics; research in the fields of science, technology, medicine and health, namely, tissue culture maintenance and harvest, DNA and RNA extraction, protein purification, nucleic sequencing, analysis and synthesis of oligonucleotides and other molecules, analysis of absorption, distribution, metabolism, and excretion of pharmacological and molecular compounds, cell-based and enzyme assays, in vitro and in vivo phenotypic analysis, and molecular compound characterization, for others for use in life science research and biotechnology research; consultation services in the field of science and technology, namely, consultation in the field of cell and tissue culture maintenance and harvest, DNA and RNA extraction, protein purification, nucleic sequencing, analysis and synthesis of oligonucleotides and other molecules, analysis of absorption, distribution, metabolism, and excretion of pharmacological and molecular compounds, cell-based and enzyme assays, in vitro and in vivo phenotypic analysis, molecular compound characterization, sample preparation and management, consumable laboratory product management, tracking usage, maintenance and management of assets and inventory, and scientific efficiencies and productivity, for use in life science research and biotechnology research; medical laboratory, pharmaceutical research and laboratory diagnostic services in the field of DNA and RNA extraction, protein purification, nucleic sequencing, analysis and synthesis of oligonucleotides and other molecules, analysis of absorption, distribution, metabolism, and excretion of pharmacological and molecular compounds, perform cell-based and enzyme assays, in vitro and in vivo phenotypic analysis, and molecular compound characterization for others for use in life science research and biotechnology research; laboratory support services, namely, cell and tissue culture maintenance and harvest, preparation of cell and tissue media, DNA and RNA extraction, protein purification, nucleic sequencing, analysis and synthesis of oligonucleotides and other molecules, analysis of absorption, distribution, metabolism, and excretion of pharmacological and molecular compounds, perform cell-based and enzyme assays, in vitro and in vivo phenotypic analysis, molecular compound characterization, sample preparation and management, consumable laboratory product management, tracking usage, maintenance and management of assets and inventory, implementation of scientific efficiencies and productivity for others for use in life science research and biotechnology research, and daily equipment start-up and shut down; planning and layout design services for laboratories; consulting services in the field of laboratory automation; Installation, maintenance, optimization, repair, and refurbishment of computer software for scientific, medical, and pharmaceutical research, analysis, and diagnostics use; Pre-move testing of laboratory equipment and post-move laboratory equipment testing and calibration for scientific, pharmaceutical, and medical research, analytical, and diagnostic laboratories | ACTIVE | — |
| 044 | Laboratory Medical services in the nature of medical analysis and diagnosis, excluding analysis and diagnosis at the point of patient care; genetic analysis and reporting services for medical purposes; nucleic acid sequencing and analysis services for medical purposes; genome sequencing and analysis services for medical purposes; DNA screening for medical purposes; consultation in the field of medicine, health and pharmaceuticals, excluding consultation at the point of patient care and in pharmacies; DNA and polynucleic acid testing services being medical diagnostic services; conducting medical tests to diagnose disease | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PERKINELMER U.S. LLC
- Other trademarks owned by PerkinElmer Health Sciences, Inc.
- Other trademarks owned by PerkinElmer Health Sciences, Inc.
- Other trademarks owned by PerkinElmer Health Sciences, Inc.
- Other trademarks in Class 035
- Other trademarks in Class 037
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ONESOURCE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 27, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 27, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 27, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 27, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 27, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 25, 2024 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jul 25, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 25, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 25, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 21, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 21, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 21, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 21, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 21, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 29, 2023 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Apr 5, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 22, 2021 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Mar 17, 2021 | APET | ASSIGNED TO PETITION STAFF | — |
| Jan 13, 2021 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Dec 8, 2020 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Sep 10, 2020 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Aug 11, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 11, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 22, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 8, 2020 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 26, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 26, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 26, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 26, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 26, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 8, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 4, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 22, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 21, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 21, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 25, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 25, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 25, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 20, 2019 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Nov 12, 2019 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Oct 28, 2019 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 24, 2019 | ALIE | ASSIGNED TO LIE | — |
| Oct 22, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 22, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 22, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 22, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 22, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 1, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 30, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 30, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 1, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 1, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 1, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 14, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 14, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 14, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 14, 2019 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jan 7, 2019 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Dec 18, 2018 | ISSR | WITHDRAWN FROM ISSUE - SENIOR ATTORNEY REQUEST | — |
| Dec 18, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 18, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 28, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 7, 2018 | ALIE | ASSIGNED TO LIE | — |
| Oct 24, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 24, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 24, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 24, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 24, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 11, 2018 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 11, 2018 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 11, 2018 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 21, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 20, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 20, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 15, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 6, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 13, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 8, 2018 | NWAP | NEW APPLICATION ENTERED | — |